"Toxic memory" via chaperone modification is a potential mechanism for rapid mallory-denk body reinduction

Hepatology

Volumn 48, Issue 3, 2008, Pages 931-942

  Strnad, Pavel ^a,b,e,f   Tao, Guo Zhong ^a   So, Phillip ^a   Lau, Kenneth ^c   Schilling, Jim ^c   Wei, Yuquan ^d   Liao, Jian ^d   Omary, M Bishr ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF ULM   (Germany)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SICHUAN UNIVERSITY   (China)

^e Stanford California and Cofounder   (United States)

^f Department of Molecular and Integrative Physiology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,4,6 TRIMETHYL 3,5 PYRIDINEDICARBOXYLIC ACID DIETHYL ESTER; CHAPERONE; CYTOKERATIN 8; GLUCOSE REGULATED PROTEIN; GLUCOSE REGULATED PROTEIN 58; GLUCOSE REGULATED PROTEIN 75; GLUCOSE REGULATED PROTEIN 78; HEAT SHOCK PROTEIN 25; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 72; ISOPROTEIN; PROTEIN P62; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CROSS LINKING; IMMUNOBLOTTING; LONG TERM EXPOSURE; MALE; MALLORY BODY; MALLORY DENK BODY; MASS SPECTROMETRY; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROCESSING; REFEEDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; CHAPERONIN 60; DICARBETHOXYDIHYDROCOLLIDINE; HEPATOCYTES; HSP70 HEAT-SHOCK PROTEINS; INCLUSION BODIES; INTERMEDIATE FILAMENTS; KERATIN-18; KERATIN-8; MALE; MICE; MICE, INBRED C3H; MOLECULAR CHAPERONES; PROTEIN FOLDING; PROTEIN ISOFORMS;

EID: 51349091610     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22430     Document Type: Article

References (49)

1. Bershadsky AD, Vasiliev JM. Cytoskeleton. New York: Plenum Press, 1988:133-154.
2. Ku N-O, Zhou X, Toivola DM, Omary MB. The cytoskeleton of digestive epithelia in health and disease. Am J Physiol 1999;277: G1108-G1137.
3. Herrmann H, Bär H, Kreplak L, Strelkov SV, Aebi U. Intermediate filaments: From cell architecture to nanomechanics. Nat Rev Mol Cell Biol 2007;8:562-573.
4. Kim S, Coulombe PA. Intermediate filament scaffolds fulfill mechanical, organizational, and signaling functions in the cytoplasm. Genes Dev 2007; 21:1581-1597.
5. Omary MB, Coulombe PA, McLean WH. Intermediate filament proteins and their associated diseases. N EnglJ Med 2004;351:2087-2100.
6. Goebel HH. Congenital myopathies with inclusion bodies: A brief review. Neuromuscul Disord 1998;8:162-168.
7. Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med 2004;10:S10-S17.
8. Der Perng M, Su M, Wen SF, Li R, Gibbon T, Prescott AR, et al. The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of alpha B-crystallin and HSP27. Am J Hum Genet 2006;79:197-213.
9. Zatloukal K, French SW, Stumptner C, Strnad P, Harada M, Toivola DM, et al. From Mallory to Mallory-Denk bodies: What, how and why? Exp Cell Res 2007;313:2033-2049.
10. Zatloukal K, Stumptner C, Fuchsbichler A, Heid H, Schnoelzer M, Kenner L, et al. p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 2002;160:255-263.
11. Macario AJ, Conway de Macario E. Sick chaperones, cellular stress, and disease. N Engl J Med 2005;353:1489-1501.
12. Jensen K, Gluud C. The Mallory body: Morphological, clinical and experimental studies (Part 1 of a literature survey). HEPATOLOGY 1994;20:1061-1077.
13. Ku NO, Strnad P, Zhong BH, Tao GZ, Omary MB. Keratins let liver live: mutations predispose to liver disease and crosslinking generates Mallory-Denk bodies. HEPATOLOGY 2007;46:1639-1649.
14. Denk H, Stumptner C, Zatloukal K. Mallory bodies revisited. J Hepatol 2000;32:689-702.
15. Bukau B, Weissman J, Horwich A. Molecular chaperones and protein quality control. Cell 2006;125:443-451.
16. Mehta K, Van Thiel DH, Shah N, Mobartan S. Nonalcoholic fatty liver disease: Pathogenesis and the role of antioxidants. Nutt Rev 2002;60:289-293.
17. Dey A, Cederbaum AI. Alcohol and oxidative liver injury. HEPATOLOGY 2006;43(Suppl):S63-S74.
18. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: From steatosis to cirrhosis. HEPATOLOGY 2006;43(Suppl):S99-S112.
19. Li J, Bardag-Gorce F, Dedes J, French BA, Amidi F, Oliva J, et al. S-adenosylmethionine prevents mallory denk body formation in drug-primed mice by inhibiting the epigenetic memory. HEPATOLOGY 2008;47: 613-624.
20. Georgopoulos C, Welch WJ. Role of the major heat shock proteins as molecular chaperones. Annu Rev Cell Biol 1993;9:601-634.
21. Ku NO, Toivola DM, Zhou Q, Tao GZ, Zhong B, Omary MB. Studying simple epithelial keratins in cells and tissues. Methods Cell Biol 2004;8: 489-517.
22. Nakamichi I, Toivola DM, Strnad P, Michie SA, Oshima RG, Baribault H, et al. Keratin 8 overexpression promotes mouse Mallory body formation. J Cell Biol 2005;171:931-937.
23. Gething MJ, Sambrook J. Protein folding in the cell. Nature 1992;355: 33-45.
24. Strnad P, Harada M, Siegel M, Terkeltaub RA, Graham RM, Khosla C, et al. Transglutaminase-2 regulates Mallory body inclusion formation and liver size. Gastroenterology 2007;132:1515-1526.
25. Van Kleef FS, De Jong WW, Hoenders HJ. Stepwise degradations and deamidation of the eye lens protein alpha-crystallin in ageing. Nature 1975;258:264-266.
26. Takemoto L, Boyle D. Increased deamidation of asparagine during human senile cataractogenesis. Mol Vis 2000;6:164-168.
27. Boros S, Wilmarth PA, Kamps B, de Jong WW, Bloemendal H, Lampi K, et al. Tissue transglutaminase catalyzes the deamidation of glutamines in lens betaB(2)- and betaB(3)-crystallins. Exp Eye Res 2008;86:383-393.
28. Nilsson MR, Driscoll M, Raleigh DP. Low levels of asparagine deamidation can have a dramatic effect on aggregation of amyloidogenic peptides: implications for the study of amyloid formation. Protein Sci 2002;11:342-349.
29. Carbone DL, Doorn JA, Kiebler Z, Sampey BP, Petersen DR. Inhibition of Hsp72-mediated protein refolding by 4-hydroxy-2-nonenal. Chem Res Toxicol 2004;17:1459-1467.
30. Carbone DL, Dootn JA, Kiebler Z, Ickes BR, Petersen DR. Modification of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic alcoholic liver disease. J Pharmacol Exp Ther 2005;315:8-15.
31. Moon KH, Hood BL, Kim BJ, Hardwick JP, Conrads TP, Veenstra TD, et al. Inactivation of oxidized and S-nitrosylated mitochondrial proteins in alcoholic fatty liver of rats. HEPATOLOGY 2006;44:1218-1230.
32. Bardag-Gorce F, Dedes J, French BA, Oliva JV, Li J, French SW. Mallory body formation is associated with epigenetic phenotypic change in hepatocytes in vivo. Exp Mol Pathol 2007;83:160-168.
33. Voellmy R. Feedback regulation of the heat shock response. Handb Exp Pharmacol 2006;172:43-68.
34. Calabrese V, Renis M, Calderone A, Russo A, Barcellona ML, Rizza V. Stress proteins and SH-groups in oxidant-induced cell damage after acute ethanol administration in rat. Free Radic Biol Med 1996;20:391-397.
35. Rakonczay Z Jr, Boros I, Jármay K, Hegyi P, Lonovics J, Takacs T. Ethanol administration generates oxidative stress in the pancreas and liver, but fails to induce heat-shock proteins in rats. J Gastroenterol Hepatol 2003;18: 858-867.
36. Fujio N, Hatayama T, Kinoshita H, Yukioka M. Induction of mRNAs for heat shock proteins in livers of rats after ischemia and partial hepatectomy. Mol Cell Biochem 1987;77:173-177.
37. Broomé U, Scheynius A, Hultcrantz R. Induced expression of heat-shock protein on biliary epithelium in patients with primary sclerosing cholangitis and primary biliary cirrhosis. HEPATOLOGY 1993;18:298-303.
38. Lee KJ, Terada K, Oyadomari S, Inomata Y, Mori M, Gotoh T. Induction of molecular chaperones in carbon tetrachloride-treated rat liver: implications in protection against liver damage. Cell Stress Chaperones 2004;9:58-68.
39. Hay DG, Sathasivam K, Tobaben S, Stahl B, Marber M, Mestril R, et al. Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach. Hum Mol Genet 2004;13:1389-1405.
40. Maatkamp A, Vlug A, Haasdijk E, Troost D, French PJ, Jaarsma D. Decrease of Hsp25 protein expression precedes degeneration of motoneurons in ALS-SODI mice. Eur J Neurosci 2004;20:14-28.
41. Cummings CJ, Mancini MA, Antalffy B, DeFranco DB, Orr HT, Zoghbi HY. Chaperone suppression of aggregation and altered subcellular protea-some localization imply protein misfolding in SCA1 Nature Genet 1998; 19:148-154.
42. Vacher C, Garcia-Oroz L, Rubinsztein DC. Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington's disease. Hum Mol Genet 2005; 14:3425-3433.
43. Meriin AB, Sherman MY. Role of molecular chaperones in neurodegenerative disorders. Int J Hyperthermia 2005;21:403-419.
44. Liao J, Lowthert LA, Ghori N, Omary MB. The 70-kDa heat shock proteins associate with glandular intermediate filaments in an ATP-dependent manner. J Biol Chem 1995;270:915-922.
45. Janig E, Stumptner C, Fuchsbichler A, Denk H, Zatloukal K. Interaction of stress proteins with misfolded keratins. Eur J Cell Biol 2005; 84:329-339.
46. Tephly TR, Coffman BL, Ingall G, Ziet-Har MS, Goff HM, Tabba HD, et al. Identification of N-methylprotoporphyrin IX in livers of untreated mice and mice treated with 3, 5-diethoxycarbonyl- 1, 4-dihydrocollidine: source of the methyl group. Arch Biochem Biophys 1981; 212:120-126.
47. Cadrin M, French SW, Wong PT. Alteration in molecular structure of cytoskeleton proteins in griseofulvin-treated mouse liver: A pressure tuning infrared spectroscopy study. Exp Mol Pathol 1991;55:170-179.
48. Kachi K, Wong PT, French SW. Molecular structural changes in Mallory body proteins in human and mouse livers: An infrared spectroscopy study. Exp Mol Pathol 1993;59:197-210.
49. Zatloukal K, Fesus L, Denk H, Tarcsa E, Spurej G, Bock G. High amount of epsilon-(gamma-glutamyl)lysine cross-links in Mallory bodies. Lab Invest 1992;66:774-777.